Sanne A M Hendrickx, Ellie B M Landman, Ydo V Kleinlugtenbelt
{"title":"骨科患者出院后阿片类药物使用模式被低估：一项探索性研究。","authors":"Sanne A M Hendrickx, Ellie B M Landman, Ydo V Kleinlugtenbelt","doi":"10.1080/17581869.2025.2473871","DOIUrl":null,"url":null,"abstract":"<p><strong>Aim: </strong>This study explores morphine use among patients after discharge following total hip (THA) or knee arthroplasty (TKA).</p><p><strong>Method: </strong>Morphine use was monitored for 14 days post-discharge. Patients recorded their morphine intake and reported pain using a Visual Analog Scale (VAS). Incomplete reports were excluded from longitudinal analysis. Median tablet count and total morphine use in milligram equivalents (MME) were calculated. Patients were categorized as non-users (0 mmE), short-term users (<100 mmE), and consistent users (>100 mmE).</p><p><strong>Results: </strong>Of the 67 patients, six dropped out. Among the remaining, 22 (36.7%) took no morphine, while 38 (63.3%) took at least one dose, with a median VAS-score of 5. Short-term users (<i>n</i> = 19) averaged a total of 40 mmE, mainly in the first three days, while consistent users (<i>n</i> = 15) averaged in total 220 mmE during follow-up, tapering gradually. After 14 days, 3% continued usage. Four patients with incomplete data were excluded. However, for those was found that this was due to or related to the fact that they used a large amount of morphine.</p><p><strong>Conclusion: </strong>Most patients used minimal or no morphine, tapering off within two weeks.</p>","PeriodicalId":20000,"journal":{"name":"Pain management","volume":" ","pages":"199-204"},"PeriodicalIF":1.4000,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12001552/pdf/","citationCount":"0","resultStr":"{\"title\":\"Post-discharge opioid utilization patterns in orthopedic patients are underestimated: an explorative study.\",\"authors\":\"Sanne A M Hendrickx, Ellie B M Landman, Ydo V Kleinlugtenbelt\",\"doi\":\"10.1080/17581869.2025.2473871\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Aim: </strong>This study explores morphine use among patients after discharge following total hip (THA) or knee arthroplasty (TKA).</p><p><strong>Method: </strong>Morphine use was monitored for 14 days post-discharge. Patients recorded their morphine intake and reported pain using a Visual Analog Scale (VAS). Incomplete reports were excluded from longitudinal analysis. Median tablet count and total morphine use in milligram equivalents (MME) were calculated. Patients were categorized as non-users (0 mmE), short-term users (<100 mmE), and consistent users (>100 mmE).</p><p><strong>Results: </strong>Of the 67 patients, six dropped out. Among the remaining, 22 (36.7%) took no morphine, while 38 (63.3%) took at least one dose, with a median VAS-score of 5. Short-term users (<i>n</i> = 19) averaged a total of 40 mmE, mainly in the first three days, while consistent users (<i>n</i> = 15) averaged in total 220 mmE during follow-up, tapering gradually. After 14 days, 3% continued usage. Four patients with incomplete data were excluded. However, for those was found that this was due to or related to the fact that they used a large amount of morphine.</p><p><strong>Conclusion: </strong>Most patients used minimal or no morphine, tapering off within two weeks.</p>\",\"PeriodicalId\":20000,\"journal\":{\"name\":\"Pain management\",\"volume\":\" \",\"pages\":\"199-204\"},\"PeriodicalIF\":1.4000,\"publicationDate\":\"2025-04-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12001552/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Pain management\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1080/17581869.2025.2473871\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/3/2 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q4\",\"JCRName\":\"CLINICAL NEUROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pain management","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/17581869.2025.2473871","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/3/2 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
Post-discharge opioid utilization patterns in orthopedic patients are underestimated: an explorative study.
Aim: This study explores morphine use among patients after discharge following total hip (THA) or knee arthroplasty (TKA).
Method: Morphine use was monitored for 14 days post-discharge. Patients recorded their morphine intake and reported pain using a Visual Analog Scale (VAS). Incomplete reports were excluded from longitudinal analysis. Median tablet count and total morphine use in milligram equivalents (MME) were calculated. Patients were categorized as non-users (0 mmE), short-term users (<100 mmE), and consistent users (>100 mmE).
Results: Of the 67 patients, six dropped out. Among the remaining, 22 (36.7%) took no morphine, while 38 (63.3%) took at least one dose, with a median VAS-score of 5. Short-term users (n = 19) averaged a total of 40 mmE, mainly in the first three days, while consistent users (n = 15) averaged in total 220 mmE during follow-up, tapering gradually. After 14 days, 3% continued usage. Four patients with incomplete data were excluded. However, for those was found that this was due to or related to the fact that they used a large amount of morphine.
Conclusion: Most patients used minimal or no morphine, tapering off within two weeks.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
